Insights into Cartesian Therapeutics Q4 Earnings

Cartesian Therapeutics (NASDAQ:RNAC) just disclosed its Q4 earnings on Monday, March 9, 2026 at 07:00 AM. Here’s a brief overview of the earnings report. Earnings Cartesian Therapeutics missed estimated earnings by -73.75%, reporting an EPS of $-1.39 versus an...

Dianthus Therapeutics Earnings Review: Q4 Summary

Dianthus Therapeutics (NASDAQ:DNTH) announced its Q4 earnings on Monday, March 9, 2026 at 07:09 AM. Here’s a breakdown of the earnings report. Earnings Dianthus Therapeutics missed estimated earnings by -41.58%, reporting an EPS of $-1.43 versus an estimate of...

ARS Pharmaceuticals: Q4 Earnings Insights

ARS Pharmaceuticals (NASDAQ:SPRY) reported its Q4 earnings results on Monday, March 9, 2026 at 07:00 AM. Here’s what investors need to know about the announcement. Earnings ARS Pharmaceuticals beat estimated earnings by 8.7%, reporting an EPS of $-0.42 versus an...